Journal of SAFOMS

Register      Login

VOLUME 2 , ISSUE 1 ( January-June, 2014 ) > List of Articles

RESEARCH ARTICLE

Study of Efficacy and Safety of Ormeloxifene in the Management of Dysfunctional Menorrhagia

Uma Gupta, Kumkum Shrivastava, Gunjan Katiyar, Ayesha Arif, Narendra Kumar Gupta

Citation Information : Gupta U, Shrivastava K, Katiyar G, Arif A, Gupta NK. Study of Efficacy and Safety of Ormeloxifene in the Management of Dysfunctional Menorrhagia. J South Asian Feder Menopause Soc 2014; 2 (1):1-4.

DOI: 10.5005/jp-journals-10032-1022

Published Online: 01-06-2014

Copyright Statement:  Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin. Gynecol Obstet Invest 2011;71(4):281-284.
  2. Medical management of dysfunctional uterine bleeding. Baillieres Best Pract Res Clin Obstet Gynaecol 1999 Jun;13(2):189-202.
  3. Medical management of menorrhagia. West J Med 2000 Apr;172(4):253-255.
  4. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med Res Rev 2001;21(4):302-347.
  5. Effect of ormeloxifene, a selective estrogen receptor modulator, on biomarkers of the endometrial receptivity and pinopode development and its relationship with fertility and infertility in Indian subjects. Fertil Steril 2009 Jun;91(6):2298-2307.
  6. Centchroman a better alternative for hormonal oral contraceptive pills. Int J Pharm Bio Sci 2011 Jan-Mar;2(1):587-592.
  7. ‘The efficacy and safety of ormeloxifene in the management of menorrhagia: a pilot study’. J Obstet Gynaecol 2009;35(4):746-752.
  8. The role of sevista in the management of dysfunctional uterine bleeding. J Clin Diagn Res 2013 Jan;7(1):132-134.
  9. Ormeloxifene a selective estrogen receptor modulator, for treatment of dysfunctional menorrhagia. J Obstet Gynecol Ind 2004 Jan-Feb;54(1):56-59.
  10. Efficacy of a selective estrogen receptor modulator: Ormeloxifene in management of dysfunctional uterine bleeding. J SAFOG 2010 Sep-Dec;2(6):207.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.